|
|
|
|
Vol. 9, Issue 10, 2917-2931, October 1998


*Pasteur Institute-Cenci Bolognetti Foundation, Department of Cell
and Developmental Biology, University of Rome "La Sapienza", 00185 Rome, Italy;
Department of General Physiology and
Biochemistry, University of Milan, 20133 Milan, Italy; and
§Laboratoire de Génétique Moléculaire
Bâtiment 400, Université Paris-Sud, 91405 Orsay,
France
| |
ABSTRACT |
|---|
|
|
|---|
We report here the functional characterization of an essential Saccharomyces cerevisiae gene, MPR1, coding for a regulatory proteasomal subunit for which the name Rpn11p has been proposed. For this study we made use of the mpr1-1 mutation that causes the following pleiotropic defects. At 24°C growth is delayed on glucose and impaired on glycerol, whereas no growth is seen at 36°C on either carbon source. Microscopic observation of cells growing on glucose at 24°C shows that most of them bear a large bud, whereas mitochondrial morphology is profoundly altered. A shift to the nonpermissive temperature produces aberrant elongated cell morphologies, whereas the nucleus fails to divide. Flow cytometry profiles after the shift to the nonpermissive temperature indicate overreplication of both nuclear and mitochondrial DNA. Consistently with the identification of Mpr1p with a proteasomal subunit, the mutation is complemented by the human POH1 proteasomal gene. Moreover, the mpr1-1 mutant grown to stationary phase accumulates ubiquitinated proteins. Localization of the Rpn11p/Mpr1p protein has been studied by green fluorescent protein fusion, and the fusion protein has been found to be mainly associated to cytoplasmic structures. For the first time, a proteasomal mutation has also revealed an associated mitochondrial phenotype. We actually showed, by the use of [rho°] cells derived from the mutant, that the increase in DNA content per cell is due in part to an increase in the amount of mitochondrial DNA. Moreover, microscopy of mpr1-1 cells grown on glucose showed that multiple punctate mitochondrial structures were present in place of the tubular network found in the wild-type strain. These data strongly suggest that mpr1-1 is a valuable tool with which to study the possible roles of proteasomal function in mitochondrial biogenesis.
| |
INTRODUCTION |
|---|
|
|
|---|
Nucleocytoplasmic interactions have often been
studied by looking for nuclear suppressors of mitochondrial mutations.
We have previously described the mpr1-1 mutation, which was
isolated as a nuclear suppressor of a mitochondrial mutation that
resulted in defective tRNA processing (Zennaro et al., 1989
;
Rinaldi et al., 1994
). Although the mechanism of the
mitochondrial suppression was unclear, the MPR1 gene was
found to be essential (Rinaldi et al., 1995
), and its
temperature-sensitive allele, mpr1-1, caused a pleiotropic
phenotype. The deduced amino acid sequence of Mpr1p (Rinaldi et
al., 1995
) clearly indicated that it belongs to a conserved gene
family and exhibits high identity to the recently published sequence of
the human proteasomal regulatory subunit Poh1p (Spataro et
al., 1997
).
Control of many cellular activities (such as metabolic adaptation, cell
differentiation, cell cycle control, and stress response) requires
degradation of regulatory proteins such as cyclins, transcriptional activators and repressors (for reviews see Nurse, 1990
; Rechsteiner et al., 1993
; Hochstrasser 1995
; Murray, 1995
; Hilt and Wolf
1996
; King et al., 1996
). The ATP- and ubiquitin-dependent
26S proteasome is a functional complex capable of recognizing and
degrading such regulatory proteins when they are to be eliminated
(Peters, 1994
). The 26S proteasome is known to be composed of two
subunits: the 19S regulatory particle recognizes and unfolds
ubiquitinated proteins, which are then degraded by the 20S proteolytic
subunit. In Saccharomyces cerevisiae, the structure of the
latter subunit has been resolved by crystallography, and all the
corresponding genes have been identified (Groll et al.,
1997
). Recently also the 19S regulatory particle has been isolated, and
its 17 protein subunits have been isolated and sequenced. One of them,
called Rpn11p, was found to be the product of the MPR1 gene
we had studied (Glickman et al., 1998
). We therefore will
call this gene RPN11/MPR1.
In S. cerevisiae, the specific roles of several components
of the proteasomal regulatory complex have been identified by the study
of the effects of mutations in the corresponding genes. Some of the
components are known to be involved in cell cycle progression. Ghislain
et al. (1993)
have described two thermosensitive mutations
(cim3 and cim5), which are colethal with
cdc28-1N. In these mutant strains, the cell cycle was
arrested in G2-M upon shifting to the nonpermissive
temperature (Ghislain et al., 1993
). Mutations in other
proteasomal genes resulted in a similar arrest of the cell cycle and/or
a failure to replicate the spindle pole body (McDonald and Byers,
1997
). Other mutations, such as one affecting the regulatory subunit
Nin1p (Kominami et al., 1994
), result in a block both in the
G1-S and the G2-M transitions. In many cases,
these mutations were accompanied by additional effects such as the
accumulation of ubiquitinated proteins.
Despite our knowledge of the structure and subunits of the proteasome,
little is known about the intracellular localization of the proteasome
complex. Immunocytochemical studies have revealed the presence of
proteasomes in the nucleus and in the cytoplasm of a variety of cells
and tissues. However, the intracellular distribution of proteasomes
varies during the cell cycle and during development in higher
eukaryotes, and several observations point to a highly dynamic state of
proteasomes in the cell (Amsterdam et al., 1993
; Rivett
1993
; Peters et al., 1994
; Dawson et al., 1995
).
In this report, we describe the function and localization of Mpr1p, and we analyze in detail the pleiotropic effects of a mutated allele (mpr1-1) of the RPN11/MPR1 gene. This is the first case in which a clear mitochondrial phenotype can be associated with a proteasomal mutation.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Strains, Plasmids, and Media
The yeast strains and plasmids used in this study are listed in Table 1.
|
Yeast Culture Media. Rich medium was YP (1% bactopeptone and 1% yeast extract), containing 2% glucose (YPD), 2% glycerol (YPG), or 2% galactose (YPGal). Minimal medium was WO (0.17% yeast nitrogen base, 0.5% ammonium sulfate, and 2% glucose). All media were supplemented with 2.3% bacto agar (Difco, Detroit, MI) for solid media, and WO was supplemented with the appropriate nutritional requirements according to the phenotype of the strains.
Isolation of the RPN11/MPR1 Gene.
To isolate the gene that
complements the growth defect of the mpr1-1 mutant, the
mutant strain R117/a12 was transformed with a nuclear DNA library
constructed in the YCp50 centromeric vector (Rose et al.,
1987
). One plasmid (pYC31), containing an insert of 3.1 kb,
complemented the thermosensitive phenotype of the mutant strain. This
insert contained a truncated NIC96 gene and two unknown ORFs. The ORF responsible for the suppression was present in an EcoRI-BamHI fragment of 2.4 kb (YCpMPR1). The
gene was called MPR1 (GenBank accession number X79561).
Construction of W303-mpr1 Strain.
Isogenic strains in a W303
genetic context have been constructed as follows. The W303-1B haploid
strain was transformed with the circular integrative plasmid YIplac211
(Gietz and Sugino, 1988
) containing mpr1-1 and
URA3 as selectable markers (pYI-mpr1). Twenty-five
URA3 transformants of the resulting strain W303-pI were
cured with 5FOA; among the URA3 clones, four showed the same growth defect as the strain R117/a12, indicating that the
RPN11/MPR1 gene had been excised with the URA3
marker: the substitution of RPN11/MPR1 with
mpr1-1 in the W303-1B strain results in the same phenotype
as the one observed in R117/a12. The W303-1B strain containing
mpr1-1 was called W303-mpr1, whereas the same strain having
retained the wild-type MPR1 gene was called W303-MPR1. Correct integration of the mutant allele was demonstrated by PCR analysis.
Allelism Test between the Isolated MPR1 Gene and the mpr1-1 Mutation. The first step was to construct a haploid strain deleted for MPR1 and made viable by the presence of the episomal plasmid YEpMPR1 (LEU2). This was done by sporulating the W303/5 diploid strain (MPR1/mpr1::URA3) transformed with the same plasmid YEpMPR1. A viable spore was then crossed with the mutant W303-mpr1, the corresponding diploid was sporulated, and tetrad analysis was performed. In case of allelism two types of spores should be obtained: 1) W303-mpr1::URA3 + YEpMPR1 (which cannot lose the plasmid); and 2) W303-mpr1 + YEpMPR1 (which can lose the plasmid). This is was what we obtained.
Construction of GFP Plasmids.
To construct the p100GFP
plasmid, the wild-type GFP was isolated as a
KpnI-PstI fragment from plasmid TU65 (a kind
gift from Dr. M. Chalfie, Department of Biological Sciences, Columbia
University, New York, NY) (Chalfie et al., 1994
).
After blunting the KpnI overhang with T7 polymerase,
GFP was ligated into
SmaI-PstI-restricted pEMBLYex4 (episomal
plasmid; Baldari et al., 1987
) under the control of the
UASgal1-10/CYC1 promoter. The fusion
RPN11/MPR1-GFP was constructed as follows. The
GFP gene from the pRSETB8 plasmid was cloned in pBluescript
KS+ (Stratagene, La Jolla, CA) lacking the EcoRI site
of the polylinker (pKS-EcoRI). This plasmid was obtained by
ligation of pBluescript KS+ digested with the restriction enzymes
EcoRV and SmaI (resulting plasmid, KSpGFP). Two
oligonucleotides with an EcoRI site at the extremities were
used to amplify the RPN11/MPR1 promoter region and the full
gene except the stop codon. This fragment of 1452 bp was first cloned
in the pCRII plasmid (resulting plasmid, pCRII-MPR1) and then cloned in
KSpGFP (resulting plasmid, KSpMPR1-GFP). This construction was also
cloned in a centromeric and multicopy plasmid (YEpMPR1-GFP and
YCpMPR1-GFP).
Construction of the Yeast Plasmid Containing the POH1 Gene. The human cDNA (pSK15) corresponding to the POH1 gene (GenBank accession number U86782) was purchased from the Research Genetics/IMAGE Consortium (Genome Systems, St. Louis, MO) (GenBank accession number AA084170). This cDNA was cloned in the plasmid pYES2 containing the galactose-activated GAL1 promoter (resulting plasmid, pYES-POH1).
Transformation Procedures
Transformation of the wild-type strain was done with a standard
lithium chloride procedure (Ito et al., 1983
). The mutant strain has a low-efficiency transformation phenotype and had to be
transformed by the protoplast procedure: a culture of 50 ml in
exponential growth phase was harvested and resuspended in
10 ml of 1 M sorbitol, 20 mM dithiothreitol, and 10 mM EDTA (pH 8) and
incubated for 10 min at room temperature. After centrifugation cells
were resuspended in 10 ml of 1 M sorbitol containing 0.5 mg of
cytohelicase (Sigma, St. Louis, MO). After incubation for 10 min at
room temperature, protoplasts were harvested by centrifugation at 1500 rpm for 10 min, washed with 10 ml of 1 M sorbitol, resuspended in YPD
containing 1 M sorbitol, and incubated for 30 min at 24°C. Protoplasts were then centrifuged and resuspended in 1 M sorbitol, 10 mM Tris-HCl (pH 7.4), and 10 mM CaCl2. Plasmid DNA was
added to 100 µl of this protoplast suspension for each
transformation, and after 10 min at room temperature, 1 ml of 20%
polyethylene glycol 4000 in a 10 mM Tris-HCl (pH 7.4)/10 mM
CaCl2 solution was added. After 10 min at room temperature
and 10 min on ice, protoplasts were mixed to 10 ml of soft agar (1%
agar) containing 1 M sorbitol supplemented with the appropriate amino
acids and spread onto minimal sorbitol plates.
DNA Techniques
DNA techniques were performed as described by Sambrook et
al. (1995)
. The oligonucleotides used for mpr1-1
amplification (bold in Figure 2) are the following: IX13,
5'-CCCTACGGTCTGTTGTTGTTCTGATTCCC-3'; IX14,
5'-CCACAGATGGAAACGCATTTAATGGTGATG-3'. For GFP fusion (underlined in
Figure 2): 5'-EcoRIMPR, 5'-CGGAATTCGAATGATGGTTGCACTC-3';
3'-EcoRIMPR, 5'-GCCTTAAGTTTAATTGCCACTGAAT-3'. Induction of
[rho°] with ethidium bromide was obtained by growing the
mpr1-1 mutant and RPN11/MPR1 strains for 24 h in the presence of 25 µg/ml ethidium bromide. The
[rho°] mutants were selected by their inability to grow
on respiratory medium followed by observation of
4,6-diamidino-2-phenylindole (DAPI) staining.
Microscopy
For DAPI staining, cells were harvested during the exponential
phase on YPD and fixed with 1% formaldehyde for 30 min. DAPI was added
at the concentration of 1 µg/ml, and cells were observed by
fluorescence microscopy. The vital dye
2-(4-dimetylaminostyryl)-N-methylpyridinium iodide
(DASPMI), at the final concentration of 10
6 M, was used
to stain the wild-type and mutant strains grown at 24°C on YPD. Cells
were then observed by confocal microscopy. Cells containing the
MPR1-GFP fusion were cultured in YPD at 24°C and harvested
in logarithmic phase. Green fluorescent protein (Gfp) was detected by
confocal microscopy, and cells were photographed directly from the
culture.
Flow Cytometric Analyses
DNA content distributions were determined after staining with propidium iodide. Propidium iodide fluorescence signal intensities were acquired from a FACStarplus (Becton Dickinson, Mountain View, CA) equipped with an argon ion laser (excitation wavelength, 488 nm; laser power, 200 mW). The sample flow rate during analysis did not exceed 500-600 cells per second. Typically, 40,000 cells were analyzed per sample. Only raw data have been used to prepare the experimental figures.
Protein Analysis
For anti-ubiquitin immunoblot, yeast cell extracts
were prepared as follows. Cells were allowed to grow to stationary
phase on YPD at 24°C; half of these cultures were shifted at 36°C
for 5 h. Cells were than harvested by centrifugation and
resuspended in water. Samples were heated 10 min at 95°C; an equal
amount of glass beads was added, and cells were broken by vortexing for 30 s six times with intermitted heating (1 min at 95°C). Equal volumes of 4.5% SDS and 2.25 mM EDTA were added, and samples were vortexed and heated for 10 min at 95°C (Gerlinger et al.,
1997
). After centrifugation, protein concentration was determined, and the same quantity of proteins (40 µg) was loaded on an SDS gel (10%). Ubiquitination of total cellular proteins was assessed by
immunoblotting with rabbit anti-ubiquitin antibodies
(Sigma).
Growth Curves
Growth curves were performed at 24°C in YPD medium using a
stationary inoculum of 104 cells from cultures 2 wk old.
Every 2 h cells were counted with the Burker chamber
(Fortuna, West Germany). Routinely, viable cell count was
determined and found to correspond. The percentage of
[rho
] was determined by plating on YP plus
glucose, followed by replica plating on YP plus glycerol.
Computer Analysis
Analysis of the Mpr1p was performed with the program
COILS (Lupas's method; Lupas et al., 1991
; Lupas,
1996
) and with the Protein Sequence Analysis (PSA) server (BioMolecular
Engineering Research Center [BMERC], Boston University, Boston,
MA) (Stultz et al., 1993
; White et al.,
1994
).
| |
RESULTS |
|---|
|
|
|---|
Isolation of RPN11/MPR1 Gene
The mpr1-1 mutation was initially isolated in the
diploid strain R117 as a nuclear suppressor of a mitochondrial tRNA
mutation (ts932), resulting in defective processing of
tRNAAsp (Zennaro et al., 1989
; Rinaldi et
al., 1994
). R117 harbors a nuclear mutation that, in a
heterozygous context, can suppress the defect of mitochondrial tRNA
processing in ts932 and allows the formation of detectable amounts of
mature tRNAAsp (Rinaldi et al., 1994
). We then
constructed a haploid strain (R117/a12) containing the suppressor
allele in a wild-type mitochondrial context and found that it caused a
growth defect in rich media containing either glucose or glycerol. This
phenotype allowed us to clone the wild-type allele
RPN11/MPR1 by complementation. The isolated
RPN11/MPR1 gene was confirmed to be allelic to
mpr1-1 by standard genetic analysis (see MATERIALS AND
METHODS).
As shown in Figure 1, the
RPN11/MPR1 gene complemented the thermosensitive phenotype
of the mutant strain. RPN11/MPR1 codes for a protein of 306 amino acids (Mpr1p) (Figure 2) (Rinaldi
et al., 1995
). RPN11/MPR1 sequence (GenBank
accession number X79561) was found to be identical to the ORF YFR004W,
identified in sequence but not in function by Murakami et
al. (1995)
in the framework of the European Biotechnology
Programme on Yeast Genome Sequencing.
|
|
The RPN11/MPR1 Gene Is Essential for Viability
To construct RPN11/MPR1-deleted cells, a one-step gene
replacement method (Rothstein et al., 1991
) was used. The
URA3 gene marker was inserted into the coding region of
RPN11/MPR1 at the HpaI site (located after amino
acid 63) in the plasmid KSpMPR1 (resulting plasmid,
pKSmpr1::URA3). This construction was used to transform two
different wild-type diploid strains (W303 and FY1679, yielding strains
W303/5 and FY1679/1). Ten tetrads from each transformed strain were
dissected; only two spores were found to grow for each tetrad, and both
were auxotrophic for uracil, indicating that the zpn11/MPR1
gene disruption was lethal. The two nongrowing spores of each tetrad,
supposed to contain RPN11/mpr1::URA3 disruption, were examined under the microscope during incubation after
dissection; they stopped growing after two to three divisions with
elongated buds.
Identification of the Mutation in the mpr1-1 Gene
To determine the nucleotide change in the mpr1-1 allele, two oligonucleotides (IX13 and IX14; see MATERIALS AND METHODS) were used to amplify the mutated form of the gene (Figure 2). Total DNA was extracted from the mutant strain, and two independent PCR products were directly sequenced. The mpr1-1 allele was also cloned from a third independent amplification in the pCRII vector (pCRII-mpr1) and sequenced; in all cases, the same nucleotide changes were found; namely, a dinucleotide CC was replaced by a trinucleotide GCA causing a change of proline 276 to alanine (P276A), followed by a frame shift leading to the production of a truncated protein of 285 amino acids (Figure 2). This change resulted in the loss of the unique Sau3A restriction site in the gene. Although the presence of the wild-type gene RPN11/MPR1 on centromeric or multicopy plasmids complemented the mpr1-1 mutation, a centromeric plasmid bearing the RPN11/MPR1 gene truncated at the Sau3A restriction site was not capable of restoring the correct growth of the mutant. We conclude that the 31 C-terminal amino acids of Mpr1p are necessary for its function in cell growth.
The putative sequence of Mpr1p allowed us to predict a secondary
structure of nine repeat strand-turn-helix domains and reveals the
presence of a hypothetical "KEKE motif" (Realini et al.,
1994
). This motif can form a coiled-coils structure in the C-terminal part of the protein (Figure 2, bold type), a feature found in most
known regulatory subunits of the proteasome. The mutant form of Mpr1p
retains this domain. An other conserved domain (MPN domain), possibly
involved in the interaction with the 20S particle, has been identified
in the N-terminal part of the protein (Hofmann and Bucher, 1998
).
Growth Phenotype Associated with the mpr1-1 Mutation
The growth defect of the original mpr1-1 mutant strain R117/a12 consisted of thermosensitivity (on glucose- or glycerol-containing media) at 36°C and delayed growth at the permissive temperature of 24°C on YP plus glucose. Figure 3 shows the growth curves at 24°C on YPD of isogenic W303-MPR1 wild-type and W303-mpr1 mutant strains. The generation time of the mutant was the same as that of the wild type, and the delayed growth was due to an increased length of the lag phase. The curve was repeated several times, and the length of the lag phase was the same. In contrast, on the same rich medium containing glycerol, at 24°C growth started only after repeated transfers on YPG. The mechanism of this adaptation is presently under study but is not due to selection of revertants.
|
Pleiotropic Phenotypes of the mpr1-1 Mutant
Microscopic observation after DAPI staining of the mutant cells growing at 24°C on YP plus glucose showed that cells were enlarged and a high proportion of the yeast population exhibited very large buds compared with the wild-type strain growing in the same condition (Figure 4, A and B). Moreover, the cytoplasm of mutant cells showed the presence of abundant punctate structures not present in the isogenic wild-type strain growing on YP plus glucose. To see whether they corresponded to mitochondria, we extended the DAPI-staining analysis to a [rho°] mpr1-1 derivative (obtained by ethidium bromide treatment; see MATERIALS AND METHODS). We observed a complete absence of the above-mentioned structures in the [rho°] cells (Figure 4C). We also compared the DAPI-stained mutant and wild-type cells after a shift for 5 h at the nonpermissive temperature. In this condition, mpr1-1 cells exhibited an aberrant morphology characterized by elongated daughter cells unable to perform a further division, whereas the nucleus was mislocalized and often only present in the first bud (Figure 4E). This is better seen in the [rho°] mpr1-1 derivative (Figure 4F). Figure 4G shows the original mutant strain R117/a12 growing on YP plus glucose at 24°C and (Figure 4H) the same strain, transformed with the plasmid YCpMPR1, growing in the same condition and stained with DAPI. In the R117/a12 strain, the multiplicity of the punctate structures is even higher than in the W303-mpr1 derivative.
|
We then used the mitochondrial vital dye DASPMI, which stains functional mitochondrial membranes, to directly visualize the mitochondria. Observation of stained mutant cells by confocal microscopy, with spatial reconstruction of 0.2-µm sections, confirmed the identity of the punctate structures with mitochondria, whereas in the wild-type strain grown at 24°C, thread-like structures were present (Figure 5).
|
Flow Cytometry Analysis of the mpr1-1 Mutant
The total DNA content of cells was estimated by flow cytometry after growth on YPD to midexponential phase at 24°C and after a subsequent shift for 3 or 5 h to the nonpermissive temperature. To evaluate the contribution of mitochondrial DNA to the observed profiles, we performed the experiments also in the [rho°] derivatives of the W303-MPR1 and W303-mpr1 strains. Results are reported in Figure 6. Although at 24°C the four flow cytometry profiles were substantially similar except for a slightly lower DNA content in the two [rho°] strains, the shift to 36°C for 5 h produced a dramatic effect in the mpr1-1 strains, with amounts of DNA per cell in a region extending up to >7C in the [rho+] and to 6C in the [rho°] derivative. The same result was obtained with the original mutant R117/a12.
|
In other words, the increase in DNA content per cell is not restricted to an increase of nuclear DNA but reaches higher values in the [rho+] mpr1-1 strain than in the [rho°] derivative, suggesting an important contribution of mitochondrial DNA to the aberrant flow cytometry profile. This is consistent with the high mitochondrial multiplicity observed by DAPI staining.
Mpr1p Belongs to a Conserved Protein Family
The sequence of Rpn11p/Mpr1p was compared with similar proteins
present in databases. Figure 7 shows the
alignment of Mpr1p and its similar proteins. Some of these protein
sequences had been deduced from cDNA data. The Mpr1p sequence, in
particular in the N-terminal part, is well conserved from yeast to
human, whereas the C-terminal part, where the mpr1-1
mutation is localized, is less conserved. It is worth noting that Mpr1p
exhibits 68.4% identity and 74.7% similarity with the human
proteasomal Poh1p protein (Spataro et al., 1997
), and, in
fact, Glickman et al. (1998)
have demonstrated that
Rpn11p/Mpr1p is one of the subunits of the proteasomal regulatory
particle.
|
The Schizosaccharomyces pombe Pad1p, which has 64% of identity with Rpn11p/Mpr1p, has been implicated in stress response and drug resistance and reported to be a coactivator of the transcriptional factor Pap1p. We therefore examined some aspects of stress response in the mutant strain. Preliminary data showed that the mutant strain is more sensitive than the wild-type strain to the presence of cadmium and vanadate but not to H2O2 (our unpublished results). This effect is under investigation.
The Homologous Gene HsPOH1 Suppresses the Mutant Phenotype
To determine whether the function of RPN11/MPR1 is conserved, we tested the ability of the human gene to complement the mpr1-1 mutation in S. cerevisiae. The plasmid pYES-POH1 was used to transform W303-mpr1. The transformants were tested for growth at 36°C before and after promoter activation with galactose. Figure 8 shows that the POH1 gene suppressed thermosensitivity on glucose and on glycerol.
|
Localization of Mpr1p
We fused the Mpr1p protein with the Gfp from Aequorea
victoria to localize the Mpr1p protein (Chalfie et al.,
1994
; Niedenthal et al., 1996
). The construction in which
the GFP gene is fused at the 3' end of RPN11/MPR1
is described in detail in MATERIALS AND METHODS. The mutant W303-mpr1
and the wild-type W303-MPR1 strains were transformed both with
centromeric and multicopy plasmids bearing RPN11/MPR1-GFP
fusion (YCpMPR1-GFP and YEpMPR1-GFP respectively). The transformed
W303-mpr1 mutant strain grew on glucose- and on glycerol-containing
media at 36°C, thus indicating that the Mpr1p-Gfp fusion was
functional. Transformants were analyzed by confocal microscopy. The
localization of Mpr1p in W303-MPR1 is shown in Figure
9: in the tested conditions, the protein was
essentially localized in the cytoplasm, but the localization was not
uniform, suggesting that the protein might be associated with
cytoplasmic structures. No difference was observed between the mutant
and wild-type strains transformed with centromeric and multicopy
plasmids bearing Mpr1p-Gfp fusion (our unpublished results). To verify that this particular localization was not due to the Gfp alone, we
observed the localization of the Gfp expressed in the W303-MPR1 strain.
The p100GFP plasmid, containing the GFP gene under the control of a galactose-inducible yeast promoter (see MATERIALS AND
METHODS), was used to transform the W303-MPR1 strain. After the
induction of the promoter with galactose, transformants were observed
by confocal microscopy, and the localization of Gfp was uniform in the
cytoplasm, showing that the observed result is not obtained with the
Gfp alone.
|
The Mutant Strain Accumulates Ubiquitinated Proteins
Yeast strains with functionally attenuated proteasomes accumulate
ubiquitinated proteins (Ghislain et al., 1993
; Gordon
et al., 1993
; Yokota et al., 1996
; Kominami
et al., 1997
). We examined whether the mpr1-1
strain presented the same accumulation as described for the mutated
form of other proteasomal subunits. Total proteins were extracted from
the wild-type and mutant strains, both grown at 24°C to stationary
phase; these strains were also shifted 5 h at the nonpermissive
temperature of 36°C. As shown in Figure 10, accumulation of ubiquitinated proteins
after the shift at the nonpermissive temperature in the
mpr1-1 strain can indeed be observed.
|
| |
DISCUSSION |
|---|
|
|
|---|
RPN11/MPR1 Encodes a Proteasomal Subunit
Our results are fully consistent with those recently reported by
Glickman et al. (1998)
showing that the sequence of the
proteasomal protein Rpn11p corresponds to the deduced sequence of
MPR1 (Rinaldi et al., 1995
). In particular the
identification of Mpr1p with Rpn11p is consistent with the similarity
of the cell cycle defects to those observed in mutants of other
proteasomal subunits such as Nin1p, Sug2/Pcs1p, Cim3p/Sug1p, and Cim5p
(Ghislain et al., 1993
; Kominami et al., 1995
;
McDonald and Byers, 1997
) and by the pleiotropy of the defects observed
in the mpr1-1 mutant, including the accumulation of
ubiquitinated proteins. Moreover, the mpr1-1 mutation is
complemented by human proteasomal subunit Poh1p.
RPN11/MPR1 is an essential gene, as are most previously studied 19S proteasomal genes. The mpr1-1 mutation is a missense mutation followed by a frame shift producing premature termination. Hence the mutated protein is altered and truncated in its C-terminal part, which has been shown to be necessary to rescue the growth defect.
Pleiotropic Effects of the mpr1-1 Mutation
The main phenotypes of the mpr1-1 mutant can be summarized as follows: 1) Microscopic analysis of DAPI-stained cells grown on YP plus glucose at the permissive temperature shows enlarged cells, mostly bearing large buds and containing multiple punctate mitochondrial structures. 2) In YP medium containing glucose, the growth rate at 24°C is not decreased compared with the wild type but only delayed by a substantially longer lag phase. One might think that some factor(s) accumulated in the stationary phase must be proteolytically degraded before growth starts, or, alternatively, that a factor abnormally degraded during the stationary phase must be newly synthesized. 3) Growth on the same medium containing glycerol is much more severely impaired even at the permissive temperature. 4) At 36°C, no growth is observed, and flow cytometry profiles show that after a shift to this temperature, the DNA content per cell is strongly increased in the [rho+] cells and, to a lesser extent, in the [rho°] cells, implying an overreplication of both nuclear and mitochondrial DNA. Microscopic analysis after the shift to 36°C shows aberrant morphologies with elongated buds. Only one nucleus seems to be present, and it is often localized in the first bud. 5) The mpr1-1 mutant accumulates ubiquitinated proteins in the stationary phase of growth at 24°C and after a shift to 36°C.
Although some of these phenotypes are caused by other proteasomal mutations, the close connection between cell cycle defects and the mitochondrial phenotype had not been observed before.
Only in one other case has a relationship been observed between a
proteasomal mutation and a mitochondrial phenotype: a mutation in the
YNT1 gene, coding for a proteasomal subunit, suppresses the
mitochondrial defects (among which is a punctate mitochondrial morphology) caused by a mutated allele of YME1, a nuclear
gene coding for a mitochondrial zinc-dependent protease (Thorsness et al., 1993
; Campbell et al., 1994
).
Mitochondria contain their own protein degradation system (possibly
involved in proofreading of mitochondrial protein synthesis products),
and a relationship between the two proteolytic systems might actually
exist (Rep and Grivell, 1996
; Suzuki et al., 1997
).
Mitochondrial Morphology
Mitochondrial morphology in S. cerevisiae is highly
variable depending on growth and physiological conditions. For example, a shift from fermentation to respiration conditions results in a change
from tubular to punctate structure (Visser et al., 1995
). During mating, mitochondria form a single dynamic network with a number
of fission and fusion events (Nunnari et al., 1997
). During
meiosis, mitochondria are seen as highly organized thread-like structures, probably required for transmission to the four spores (Smith et al., 1995
).
In the mpr1-1 mutant, this dynamic situation seems to be
affected, because we do not observe the mitochondrial tubular structure usually observed in cells growing in YP plus glucose (Figure 5). The
punctate mitochondrial morphology we observe in the mpr1-1 mutant growing on rich medium containing glucose has also been observed
in the yme1 mutant altered in a mitochondrial protease. Analogous "disorganization" of the mitochondrial tubular network has also been seen in different mutants. Mutations in the
actin-encoding ACT1 gene result in an altered mitochondrial
morphology and movement during sporulation (Smith et al.,
1995
). Similar observations have been reported for mutants of the
MDM10 and MMM1 genes, which encode mitochondrial
proteins involved in mitochondrial inheritance during mitosis (Burgess
et al., 1994
; Sogo and Yaffe, 1994
). In all these cases,
round mitochondria are observed instead of tubular structures (Fisk and
Yaffe, 1997
).
Cell Cycle Progression in the mpr1-1 Mutant
The results of flow cytometry indicate that, after the shift to
36°C, a high proportion of the population has a very high DNA content
and that both nuclear and mitochondrial DNA are involved in this
increase. This is consistent with the results of DAPI staining. Several
genes have been implicated in restricting DNA replication to once per
cell cycle. Among these, cdc16 and cdc27 mutants
have been shown to overreplicate DNA by multiple rounds of replication,
without completing the cell cycle, but no effect of the
[rho°] condition had been detected (Heichman and
Roberts, 1996
). Similar observations have been carried out by Moreno
and Nurse (1994)
in S. pombe.
In the mpr1-1 [rho°] mutant, we do not
observe multiple rounds of replication of nuclear DNA but, rather, a
situation that is more reminiscent of the doa4 mutant
phenotype; in fact, highly increased amounts of nuclear DNA and similar
flow cytometry profiles have been observed in mutants of the
DOA4 gene, which codes for a deubiquitinating enzyme bearing
similarities to the human tre-2 oncogene (Papa and
Hochstrasser, 1993
; Singer et al., 1996
).
In addition to this overreplication of nuclear DNA, the mpr1-1 mutant also presents increased amounts of mitochondrial DNA. This increase might explain the suppression of the mitochondrial tRNA-processing defect initially observed in the mitochondrial mutant ts932.
Homology with Genes Involved in AP-1-dependent Transcription
Another aspect worth noting is the high degree of similarity
(64.6% identity) of Mpr1p with Pad1p of S. pombe, which has
been reported to act as a positive regulator of Pap1p-dependent
transcription. Pap1p belongs to the AP-1 protein family, which controls
the expression of genes involved in drug resistance and stress response
(Kim and Struhl, 1995
). It may be interesting to note that the
PAD1 gene, isolated in a high-copy-number plasmid conferring
pleiotropic drug resistance in fission yeast, is truncated (Shimanuki
et al., 1995
). This truncated form of PAD1 stops
at the Sau3A site, where we identified the mpr1-1
mutation. Therefore, one could envisage that the C-terminal part of the
protein might not be necessary for drug resistance.
On the other hand, the mutations present in the mpr1-1 allele are localized downstream of the above-mentioned site in the C-terminal region of the gene, which we have shown to be necessary for the suppression of the growth defect present in the mpr1-1 mutant. If the high similarity between Mpr1p and Pad1p is to be taken into account, this might suggest that different regions of the protein might be involved in the effects on growth and stress response. The possible involvement of Mpr1p in stress response has yet to be thoroughly investigated.
Localization of Mpr1p
The cytoplasmic localization of the Mpr1p-Gfp fusion is somewhat
surprising, because most proteasomal proteins have been shown to have a
nuclear localization (Nelson et al., 1993
; McDonald and
Byers, 1997
). In our experiment no nuclear localization was evident,
even if a presence of the protein in the nucleus cannot be ruled out.
This is similar to the case of the proteasomal subunit Nin1p, which has
been found to be essentially present in the cytoplasm in the form of
dotted structures (Kominami and Toh-e, 1994
).
Conclusion
Rpn11p/Mpr1p is a proteasomal regulatory protein that belongs to a highly conserved family. The mpr1-1 mutation is the first reported case of a mutation in this gene family. Its highly pleiotropic phenotype reflects multiple functions, including mitochondrial ones. This indicates a possible involvement of the proteasome in mitochondrial biogenesis. The mpr1-1 mutation will thus provide a unique opportunity to investigate this new aspect of yeast cell biology.
| |
ACKNOWLEDGMENTS |
|---|
We are deeply indebted to Andrea Onetti for confocal microscopy. Thanks are due to Hiroshi Fukuhara for helpful discussions and to Daniel Finley for critical reading of the manuscript. We are also indebted to Dr. Martin Chalfie for providing the GFP gene. We also thank Francesco Castelli for skillful technical assistance. This work was supported by the Commission of European Community, Human Capital and Mobility contract ERB CHRX-CT94-0520, and by Ministero Università e Ricerca Scientifica e Tecnologica-University La Sapienza Cofin 1997.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
Rinaldit{at}axcasp.caspur.it.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Nakamura and S. Hirose Regulation of Mitochondrial Morphology by USP30, a Deubiquitinating Enzyme Present in the Mitochondrial Outer Membrane Mol. Biol. Cell, May 1, 2008; 19(5): 1903 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rinaldi, L. Hofmann, A. Gambadoro, R. Cossard, N. Livnat-Levanon, M. H. Glickman, L. Frontali, and A. Delahodde Dissection of the Carboxyl-Terminal Domain of the Proteasomal Subunit Rpn11 in Maintenance of Mitochondrial Structure and Function Mol. Biol. Cell, March 1, 2008; 19(3): 1022 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gallery, J. L. Blank, Y. Lin, J. A. Gutierrez, J. C. Pulido, D. Rappoli, S. Badola, M. Rolfe, and K. J. MacBeth The JAMM motif of human deubiquitinase Poh1 is essential for cell viability Mol. Cancer Ther., January 1, 2007; 6(1): 262 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Durr, M. Escobar-Henriques, S. Merz, S. Geimer, T. Langer, and B. Westermann Nonredundant Roles of Mitochondria-associated F-Box Proteins Mfb1 and Mdm30 in Maintenance of Mitochondrial Morphology in Yeast Mol. Biol. Cell, September 1, 2006; 17(9): 3745 - 3755. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Dimmer and L. Scorrano (De)constructing Mitochondria: What For?< |